A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers—those that develop between routine screenings—before they become more advanced and harder to treat. This could potentially lead to better screening practices, earlier treatment and improved patient outcomes.
This article was originally published on MedicalXpress.com